Melanotan 2 Peptide for Sale USA | Research Grade MT-2
$34.99
Description
Melanotan 2 (MT-2) Research Peptide
Melanotan 2, commonly referred to as MT-2, is a synthetic peptide analogue derived from alpha-melanocyte-stimulating hormone (α-MSH). In scientific settings, this peptide is studied for its interaction with melanocortin receptors, which play a role in various biological signaling pathways.
Our Melanotan 2 peptide USA product is provided as a high-purity lyophilized powder, allowing researchers to conduct controlled experiments and peptide analysis within laboratory environments.
Melanotan-related peptides are frequently examined in biochemical and molecular research involving receptor activity and peptide interactions.
Product Features
- High-purity Melanotan 2 peptide
- Lyophilized powder for stability
- Research-grade laboratory compound
- Secure sterile vial packaging
- Fast shipping across the USA
Research Applications
Researchers use Melanotan 2 peptides in laboratory studies involving:
- Melanocortin receptor interactions
- Peptide signaling pathways
- Molecular and biochemical research
- Controlled laboratory experiments
This compound is intended strictly for professional laboratory research use.
Quality Assurance
Each batch of Melanotan 2 undergoes strict quality verification to ensure:
- High purity levels
- Batch consistency
- Reliable research performance
Certificates of Analysis (COA) may be available for laboratory documentation.
Storage Information
For optimal stability, Melanotan 2 should be stored in a cool, dry environment and handled according to standard laboratory storage procedures.
Shipping Information
- Secure and discreet packaging
- Professional handling of research materials
- Fast and reliable delivery within the USA
Disclaimer
This product is intended for research purposes only. It is intended for human consumption or veterinary use. By purchasing, the buyer agrees that the product will be used strictly in a qualified laboratory or research setting.





Reviews
There are no reviews yet.